{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:24:10Z","timestamp":1774679050359,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1007\/bf03190078","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T06:50:04Z","timestamp":1280904604000},"page":"121-126","source":"Crossref","is-referenced-by-count":26,"title":["Effects of imidazole antimycotics on the liver microsomal cytochrome P450 isoforms in rats: comparison ofin vitro andex vivo studies"],"prefix":"10.1007","volume":"25","author":[{"given":"S.","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03190078_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0163-7258(90)90006-N","volume":"5","author":"F.J. Gonzalez","year":"1990","unstructured":"Gonzalez F.J. (1990): Molecular genetics of P450 superfamily. Pharmacol. Ther., 5, 1\u201338.","journal-title":"Pharmacol. Ther."},{"key":"BF03190078_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/0024-3205(92)90136-D","volume":"50","author":"F.P. Guengelich","year":"1992","unstructured":"Guengelich F.P. (1992): Human cytochrome P-450 enzymes. Life Sci., 50, 1471\u20131478.","journal-title":"Life Sci."},{"key":"BF03190078_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408449209145319","volume":"22","author":"S.A. Wrighton","year":"1992","unstructured":"Wrighton S.A., Stevens J.C. (1992): The human hepatic cytochrome P450 involved in drug metabolism. Crit. Rev. Toxicol., 22, 1\u201321.","journal-title":"Crit. Rev. Toxicol."},{"key":"BF03190078_CR4","first-page":"113","volume-title":"Toxicology \u2014 The Basic Science of Poisons","author":"A. Parkinson","year":"1996","unstructured":"Parkinson A. (1996): Biotransformation of xenobiotics. In: Klaassen C.D. (ed) Toxicology \u2014 The Basic Science of Poisons, 5th edn. New York: McGraw-Hill, 113\u2013186.","edition":"5th edn."},{"key":"BF03190078_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/jama.269.12.1532","volume":"269","author":"R.L. Woosley","year":"1993","unstructured":"Woosley R.L., Chen Y., Freiman J.P., Grillis, R.A. (1993): Mechanism of the cardiotoxic actions of terfenadine. J. Am. Med. Assoc., 269, 1532\u20131536.","journal-title":"J. Am. Med. Assoc."},{"key":"BF03190078_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199427010-00001","volume":"27","author":"K.T. Kivist\u00f6","year":"1994","unstructured":"Kivist\u00f6 K.T., Neuvonen P.J., Klotz U. (1994): Inhibition of terfenadine metabolism: pharmacokinetic and pharmacodynamic consequences. Clin. Pharmacokinet., 27, 1\u20135.","journal-title":"Clin. Pharmacokinet."},{"key":"BF03190078_CR7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0026-895X(25)09239-9","volume":"41","author":"I. Pichard","year":"1992","unstructured":"Pichard I., Fabre I., Daujat M., Domergue J., Joyeux H., Maurel P. (1992): Effect of corticosteroids on the expression of cytochromes P-450 and on cylosporin A oxidase activity in primary cultures of human hepatocytes. Mol. Pharmacol., 41, 1047\u20131055.","journal-title":"Mol. Pharmacol."},{"key":"BF03190078_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0076-6879(78)52029-6","volume":"52","author":"C.R. Jefcoate","year":"1978","unstructured":"Jefcoate C.R. (1978): Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy. Methods Enzymol., 52, 258\u2013279.","journal-title":"Methods Enzymol."},{"key":"BF03190078_CR9","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1001\/jama.264.21.2788","volume":"264","author":"B.P. Monahan","year":"1990","unstructured":"Monahan B.P., Ferguson C.L., Killeavy E.S., Lloyd B.K., Troy J., Cantilena L.R. (1990): Torsades de pointes occurring in association with terfenadine use. J. Am. Med. Assoc., 264, 2788\u20132790.","journal-title":"J. Am. Med. Assoc."},{"key":"BF03190078_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF00315505","volume":"45","author":"S. Pohjola-Sintonen","year":"1993","unstructured":"Pohjola-Sintonen S., Vitassalo M., Tolvonen L., Neuvonen P. (1993): Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur. J. Clin. Pharmacol., 45, 191\u2013193.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF03190078_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0006-2952(93)90377-9","volume":"45","author":"C.F. Neville","year":"1993","unstructured":"Neville C.F., Ninomiya S.I., Shimada N., Kamataki T., Imaoka S., Funae, Y. (1993): Cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats. Biochem. Pharmacol., 45, 59\u201365.","journal-title":"Biochem. Pharmacol."},{"key":"BF03190078_CR12","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","volume":"239","author":"T. Omura","year":"1964","unstructured":"Omura T., Sato R. (1964): The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370\u20132378.","journal-title":"J. Biol. Chem."},{"key":"BF03190078_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0006-2952(88)90206-7","volume":"37","author":"J.B. Houston","year":"1988","unstructured":"Houston J.B., Humphre M.J., Matthe D., Tarbit, M.H. (1988): Comparison of two azole antifungal drugs, ketoconazole and fluconazole as modifiers of rat hepatic monooxygenase activity. Biochem. Pharmacol., 37, 401\u2013408.","journal-title":"Biochem. Pharmacol."},{"key":"BF03190078_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0090-9556(25)07324-6","volume":"21","author":"A.W. Harrell","year":"1993","unstructured":"Harrell A.W., Wheeler S.M., Pennick M., Clarke S.E., Chenery R.J. (1993): Evidence that famciclocir (BRL 42810) and its associated metabolites do not inhibit the 6\u03b2-hydroxylation of testosterone in human liver microsomes. Drug Metab. Dispos., 21, 18\u201323.","journal-title":"Drug Metab. Dispos."},{"key":"BF03190078_CR15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0090-9556(25)08600-3","volume":"18","author":"I. Pichard","year":"1990","unstructured":"Pichard I., Fabre I., Fabre G.et al. (1990): Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab. Dispos., 18, 595\u2013606.","journal-title":"Drug Metab. Dispos."},{"key":"BF03190078_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0090-9556(25)06619-X","volume":"23","author":"M.T. Donato","year":"1995","unstructured":"Donato M.T., Castell N.V., Gomez-Lechon M.J. (1995): Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metab. Dispos., 23, 256\u2013258.","journal-title":"Drug Metab. Dispos."},{"key":"BF03190078_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1023\/A:1007451911843","volume":"13","author":"A.P. Li","year":"1997","unstructured":"Li A.P., Jurima-Romet M. (1997): Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: evaluation of model drugs terfenadine and rifampin. Cell Biol. Toxicol., 13, 365\u2013374.","journal-title":"Cell Biol. Toxicol."},{"key":"BF03190078_CR18","first-page":"103","volume-title":"Drug-Drug Interactions \u2014 Scientific and Regulatory Perspectives","author":"A.P. Li","year":"1997","unstructured":"Li A.P., Jurima-Romet M. (1997): Primary hepatocyte cultures as anin vitro experimental model for the evaluation of pharmacokinetic drug-drug interaction. In: Li A.P. (ed) Drug-Drug Interactions \u2014 Scientific and Regulatory Perspectives. New York: Academic Press, 103\u2013130."},{"key":"BF03190078_CR19","first-page":"555","volume":"30","author":"E. Albengres","year":"1992","unstructured":"Albengres E., Tillement J.P. (1992): Cyclosporin and ketoconazole, drug interaction or therapeutic association? Int. J. Clin. Pharmacol. Ther. Toxicol., 30, 555\u2013570.","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"BF03190078_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJM199509073331004","volume":"33","author":"A. Keogh","year":"1995","unstructured":"Keogh A., Spratt P., McCosker C., MacDonald P., Mundy J., Kaan A. (1995): Ketoconazole to reduce the need for cyclosporin after cardiac transplantation. N. Engl. J. Med., 33, 628\u2013633.","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03190078\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T19:49:10Z","timestamp":1740340150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03190078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["BF03190078"],"URL":"https:\/\/doi.org\/10.1007\/bf03190078","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}